SLC5A2 and type 2 diabetes mellitus: In summary, the effects of SGLT2 inhibitors and GLP-1RAs on falls in persons with type 2 diabetes were investigated by prospectively following up hospitalized elderly and nonelderly individuals with type 2 diabetes for up to 5 years after discharge.